Webcast CME

Specialty - Pediatrics

 Filter Results
Length: (Optional)
Sort by: Latest Top Rated
RSV and Vaccine Hesitancy: Overview of Respiratory Vaccines and Delivery for the Clinician
3.25 / 4.00
RSV and Vaccine Hesitancy: Overview of Respiratory Vaccines and Delivery for the Clinician
Faculty: Kaitlyn Rivard, PHARMD; Trate Allen DeVolld, PharmD, RPh
CME: Yes
Length: 40 minutes
Release Date: 5/8/2024 12:00:00 AM
Expiration Date: 05/07/2026
RSV and Vaccine Hesitancy: Detection of Respiratory Viruses for the Clinician
3.67 / 4.00
RSV and Vaccine Hesitancy: Detection of Respiratory Viruses for the Clinician
Faculty: Hannah Wang, MD; Christopher Attaway, MD
CME: Yes
Length: 30 minutes
Release Date: 4/10/2024 12:00:00 AM
Expiration Date: 04/09/2026
RSV and Vaccine Hesitancy: RSV Vaccination for Older Adults
3.2 / 4.00
RSV and Vaccine Hesitancy: RSV Vaccination for Older Adults
Faculty: Ronan M Factora, MD
CME: Yes
Length: 30 minutes
Release Date: 3/13/2024 12:00:00 AM
Expiration Date: 03/12/2026
RSV and Vaccine Hesitancy: Projected Public Health Threat from Current and Emerging Respiratory Viruses
3 / 4.00
RSV and Vaccine Hesitancy: Projected Public Health Threat from Current and Emerging Respiratory Viruses
Faculty: Michaela Gack, MD
CME: Yes
Length: 30 minutes
Release Date: 2/14/2024 12:00:00 AM
Expiration Date: 02/13/2026
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
3.7 / 4.00
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD; Robert Sandhaus, MD; Lauren Palange, MS
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
3.72 / 4.00
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Robert Sandhaus, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
3.67 / 4.00
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
Faculty: Umur Hatipoglu, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
3.6 / 4.00
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Individualized Treatment Plans, Surgical and bronchoscopic lung volume reduction for Alpha-1 Patients and a Patient Testimonial
3.67 / 4.00
Individualized Treatment Plans, Surgical and bronchoscopic lung volume reduction for Alpha-1 Patients and a Patient Testimonial
Faculty: Thomas Gildea, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Risk Factors and Missed Diagnosis of Alpha-1 Liver Disease
3.68 / 4.00
Testing, Risk Factors and Missed Diagnosis of Alpha-1 Liver Disease
Faculty: Virginia Clark, MD; Shreya Sengupta, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025